An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The objective of this open-label extension is to assess the safety and tolerability of
long-term treatment of the rotigotine patch in subjects with early-stage idiopathic
Parkinson's disease